Unknown PHASE2 INTERVENTIONAL NCT00176397

Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis

PCI With DES Versus CABG for Patients With Significant Left Main Stenosis

Sponsor: University of Leipzig

Conditions Coronary Artery Disease Coronary Stenosis

Interventions Percutaneous coronary intervention (left main)

Updated 5 times since 2017 Last updated: Sep 6, 2007 Started: Aug 31, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Coronary Artery Disease and Coronary Stenosis and is currently ongoing. University of Leipzig leads this study, which shows 5 recorded versions since 2003 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Aug 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Leipzig

Data source: University of Leipzig

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leipzig, Germany